Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance

Overview of attention for article published in Frontiers in immunology, January 2023

Altmetric Badge

Mentioned by

twitter: 3 X users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 52,667 followers.

RT @FrontImmunol: New Research: Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients…

11 Jan 2023

Reply Repost Favourite

Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance https://t.co/KcoaySRx7w https://t.co/lXiYnP5S3v

11 Jan 2023

Reply Repost Favourite

New Research: Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance: Purpose To determine the safety and… https://t.co/Cmbq

10 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.